daclizumab, an immunosuppressant. ▪ INDICATIONS: It is used to help prevent acute allograft rejection in renal transplant patients. ▪ CONTRAINDICATIONS: Known hypersensitivity to this drug contraindicates its use. ▪ ADVERSE EFFECTS: Life-threatening effects are pulmonary edema, tachycardia, thrombosis, renal tubular necrosis, and hydronephrosis. Other adverse effects include headache, prickly sensation, coughing, atelectasis, congestion, constipation, abdominal pain, pyrosis, hypertension, bleeding, oliguria, dysuria, renal damage, and impaired wound healing. Common side effects include chills, tremors, dyspnea, wheezing, vomiting, nausea, and diarrhea.
